RPS6KA3 and breast cancer: Based on the data collected from microarray, the OS of breast cancer patients is higher in RSK2 high-expression patients than that in RSK2 low-expression patients, and with the increase of RSK2 expression, the potential of distant metastasis and lymph node infiltration decreased.